The uses of traditional Chinese herbal medicines (TCHM) in forms of extracts for anti-cancer purpose have been practiced in China since 3,000 B.C. However, most of the TCHMs that have been claimed to possess anti-cancer potential are still not experimentally proved and/or the underlying mechanistic actions were not defined. Recently, we have reported the principal mechanisms involved in the anomalous fruit extract of Gleditsia sinensis Lam (GSE) induced cancer cell death. Furthermore, we also continued our study on three other TCHMs including the fresh juice of Scutellaria barbata (SBJ) and warmed water extract of Radix Sophorae Tonkinensis (RSTE) (Sophora subprostrata C. et T. C) and Brucea javanica (BJE) (Fructus bruceae). On the other hand, we have also investigated the possible use of microbial fermentation products in the forms of either dried biomass (Phaffia rhodozyma) or fermented extract (effective micro-organism fermentation extract, EM-X). Taken together, we believe that the accumulation of experimental and clinical evidences could further sustain the scientific base for the clinical use of both TCHMs and microbial fermentation products in the foreseeing future.
|Number of pages||9|
|Publication status||Published - 1 Sep 2005|
- Microbial fermentation products
- Traditional Chinese medicine
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology